Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Cancer (Oxford, England : 1990)|December 16, 2019
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancerJustyna Mierzynska, Mekdes Taye, Madeline Pe, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2024
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across EuropeMichail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
NPJ Breast Cancer|March 7, 2025
Machine learning-based spatial characterization of tumor-immune microenvironment in the EORTC 10994/BIG 1-00 early breast cancer trialIoannis Zerdes, Alexios Matikas, Artur Mezheyeuski, et al.
BMC Cancer|August 7, 2021
Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trialAlex De Caluwé, Laurence Buisseret, Philip Poortmans, et al.
EMBO Molecular Medicine|June 2, 2017
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclibEric Raspé, Katia Coulonval, Jaime M Pita, et al.
NPJ Breast Cancer|September 22, 2021
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancerAndrea Gombos, David Venet, Lieveke Ameye, et al.
NPJ Breast Cancer|December 5, 2025
Personalized ctDNA detection and genomic profiling in the NeoRHEA StudyAlexandra Stanciu, Elisa Agostinetto, Andreas Papagiannis, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
European Journal of Cancer (Oxford, England : 1990)|June 13, 2016
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trialMichail Ignatiadis, Brigitte Rack, Francoise Rothé, et al.
Plos One|January 26, 2011
HER2-positive circulating tumor cells in breast cancerMichail Ignatiadis, Françoise Rothé, Carole Chaboteaux, et al.
Pageof 10